Virtus Investment Advisers’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,504
Closed -$1.04M 632
2024
Q4
$1.04M Buy
49,504
+25,160
+103% +$582K 0.81% 23
2024
Q3
$548K Buy
24,344
+9,600
+65% +$185K 0.43% 67
2024
Q2
$247K Hold
14,744
0.21% 156
2024
Q1
$191K Sell
14,744
-8,000
-35% -$95.9K 0.14% 195
2023
Q4
$263K Hold
22,744
0.2% 143
2023
Q3
$290K Buy
22,744
+6,200
+37% +$87.9K 0.2% 127
2023
Q2
$227K Buy
+16,544
New +$237K 0.15% 172

Other funds holding PAHC

Virtus Investment Advisers's PAHC Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Phibro Animal Health (PAHC) in Q1 2025, closing a stake of 49,504 shares — an estimated $1.04M sold.

Virtus Investment Advisers first reported a position in PAHC in Q2 2023 and held it in 7 quarters. The position peaked at $1.04M in Q4 2024. 182 funds tracked by Wall St. Rank hold PAHC as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Phibro Animal Health position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 49,504 Phibro Animal Health shares in Q1 2025, an estimated $1.04M.
  • Virtus Investment Advisers first reported a position in Phibro Animal Health in Q2 2023 and held it in 7 quarters.
  • Virtus Investment Advisers's Phibro Animal Health position peaked at $1.04M in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.